For instance, a study found that 89% of endometrial serous carcinoma (ESC) cases exhibited positive NRF2 expression, whereas only 28% of endometrioid carcinoma cases showed similar levels (107). The gene discussed is NFE2L2; the disease is endometrioid adenocarcinoma.